24小时热门版块排行榜    

查看: 1205  |  回复: 1

hanjinsong8039

金虫 (小有名气)

[交流] [Postdoc] cancer immunology and host-microbiome interaction 宾大博后招生 已有1人参与

Postdoc Advertisement 博士后招生,欢迎大家联系

The Jin laboratory at the Perelman School of Medicine, University of Pennsylvania is recruiting multiple postdocs with diverse backgrounds and expertise to work at the forefront of cancer immunology and host-microbiome interaction.

Please visit our lab website (https://www.ccjinlab.com/) for detailed information!

About the PI:

Dr. Chengcheng Jin graduated from Tsinghua University with B.S. in Biological Sciences in 2007. She obtained her Ph.D. from Yale University, where she worked in the laboratory of Dr. Richard Flavell to study innate immune receptors in metabolic and tissue homeostasis. Then she joined Dr. Tyler Jacks’ laboratory at MIT to investigate microbiota-immune interaction in the tumor microenvironment. Her most recent work demonstrated the critical role of microbiota-immune crosstalk in promoting inflammation and tumor progression in lung cancer. Over the past twelve years of her doctoral and postdoctoral studies, Dr. Jin has developed a strong research program elucidating the mechanisms by which the immune system
senses diverse endogenous or exogenous signals to regulate various physiological or pathological processes. She has published a number of first or co-first author research articles in top journals including Cell, Science, Nature as well as review papers. Dr. Jin has also been recognized by many awards, including the NIH Pathway to Independence Award (K99/R00), the Helen Hay Whitney postdoctoral fellowship and the DOD Lung Cancer Research Concept Award.

Dr. Jin will join the Perelman School of Medicine at the University of Pennsylvania as a tenure-track
Assistant Professor starting January 2020. Her laboratory will be affiliated with the Department of Cancer
Biology, the Institute for Immunology and the Penn-CHOP Microbiome Program.

Research Areas:

The pathogenesis of cancer involves not only intrinsic genetic alterations in tumor cells but also the failure of immune surveillance and unresolved inflammation. However, it is not well understood how host-intrinsic or environmental factors direct the immune response towards tumor-promoting inflammation versus anti-tumor immunity during tumor progression. In particular, mucosal surfaces exposed to the external environment are colonized by a vast number of microbes, collectively referred to as the commensal microbiota. The work from us and others have just begun to unveil the critical role of commensal microbiome in shaping the tumor microenvironment (TME) to regulate the tumor-immune interactions. This is an area of tremendous opportunity for significant breakthroughs in cancer research.

The Jin lab will explore the fascinating interplay between the host immune system, commensal microbiota and developing tumor cells in cancer development and treatment, using a combination of genetically engineered mouse models and state-of-the art technologies including multi-omics, advanced imaging, and CRIPSR/cas9 based gene editing tools. Specifically, the Jin lab will be at the forefront of:
(1) Understanding how immune responses initiate and evolve over time as tumors arise de novo and
progress;
(2) Defining the molecular and cellular mechanisms by which the immune system senses and
responds to microbiota-derived or tumor-intrinsic signals in the TME to regulate tumor growth and cancer
responses to therapies.

Postdoc positions:

The Jin lab is looking for highly motivated and talented scientists to join our team and address the fundamental questions in cancer immunology and mucosal immune-microbiota interaction. Candidates with Ph.D., M.D., or equivalent degrees who are broadly interested in cancer biology, immunology, microbiology, mouse genetics, bioinformatics or related areas are welcome to apply!

Please email your CV, a brief description of your previous work and your future research interests and contact information for three references to be sent to ccjin@mit.edu or jinlab.upenn@gmail.com if interested.

Complete publication list of Dr. Jin:
https://www.ncbi.nlm.nih.gov/myn ... ibliography/public/
回复此楼

» 本帖附件资源列表

  • 欢迎监督和反馈:小木虫仅提供交流平台,不对该内容负责。
    本内容由用户自主发布,如果其内容涉及到知识产权问题,其责任在于用户本人,如对版权有异议,请联系邮箱:xiaomuchong@tal.com
  • 附件 1 : Postdoc_Advertisement_Jin_Lab.pdf
  • 2019-09-03 12:27:18, 75.31 K

» 猜你喜欢

~~
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zyxl

铜虫 (小有名气)


小木虫: 金币+0.5, 给个红包,谢谢回帖
之前有免疫研究初步经历,现在做纯细胞生物学,生化、细胞、分子手段比较擅长,不知道是否合适。

发自小木虫IOS客户端
2楼2019-09-11 23:39:40
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 hanjinsong8039 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] 时间戳今天,20号变了 +5 archvillain 2026-08-20 5/250 2026-08-22 06:12 by hui_daxiao
[基金申请] 2026国自然函评费到账 +9 羊腰板 2026-08-21 9/450 2026-08-22 00:03 by anji999
[基金申请] 建议基金发布提前给出明确的时间点 +10 kulium 2026-08-21 13/650 2026-08-21 21:58 by alongwaytogo
[基金申请] 看来今天不会放榜了? +8 chengyan1220 2026-08-21 11/550 2026-08-21 17:52 by dcqxinyang
[基金申请] 时间戳又变了 +13 wuchongjun 2026-08-20 19/950 2026-08-21 17:21 by 紫杉醇
[基金申请] 让我中一个面上吧! +11 大萍1987 2026-08-20 13/650 2026-08-21 14:48 by 20120902066
[基金申请] 人气不行了 +7 fansofjerry 2026-08-21 7/350 2026-08-21 14:13 by Vivilian
[基金申请] 感觉是下周放榜了 +7 angus9576 2026-08-17 12/600 2026-08-21 13:38 by weiyin
[基金申请] 我面上完蛋了 +7 且听虎啸 2026-08-20 8/400 2026-08-21 12:31 by 酷酷墨镜
[基金申请] 只有每年这种时候来逛逛小木虫 +23 yaoyewhu2008 2026-08-20 25/1250 2026-08-21 12:19 by Poppy1104
[基金申请] 什么时候开奖? +7 CrisMessi 2026-08-18 7/350 2026-08-21 12:15 by weiyin
[基金申请] 今天基金会出结果吗?20260819 +15 kkkl_v 2026-08-19 16/800 2026-08-21 11:22 by 365372687
[基金申请] 应该是下周三26日公布了吧? +4 哈哈蛤? 2026-08-21 4/200 2026-08-21 10:58 by Vivilian
[基金申请] 今天放榜没戏了吧 +9 yuleib84 2026-08-19 11/550 2026-08-21 10:06 by gltch
[基金申请] 今天系统多次维护,明天很可能放榜! +10 zju2000 2026-08-16 11/550 2026-08-20 20:02 by cl479861084
[基金申请] 重要消息,中午系统在维护 +11 yuleib84 2026-08-18 12/600 2026-08-20 11:09 by xskun
[教师之家] 为什么余额宝的年化利率越来越低?主要原因有哪些? +5 瞬息宇宙 2026-08-15 5/250 2026-08-19 20:23 by super2002521
[基金申请] 2027广东省杰青 +4 奶牛小黑 2026-08-15 10/500 2026-08-19 11:02 by wanfengnew
[基金申请] 朋友圈看到的 +6 wangzilk 2026-08-18 8/400 2026-08-19 10:55 by Haru815
[基金申请] 明天放榜? +5 Shxjjxjkx 2026-08-18 5/250 2026-08-18 18:14 by -大大大大大-
信息提示
请填处理意见